Vancomycin (VCM) loaded lipid polymer nanoparticles using various co-excipients were synthesized.
Encapsulation efficiency (EE) increased the most from 27.8% to 69.3% with the addition of ALG.
Drug release indicated that VCM-CHT had the best performance in sustained drug release of 36.1 ± 5.35% after 24h.
The EE and drug release was further mechanistically explained using molecular modelling studies.
All formulations exhibited sustained activity against both S.aureus and MRSA.